CashuNovartis AG's Strong Q4 Highlights Arrowhead Pharmaceuticals' Growth and Innovation in Biopharma8 days ago
CashuNovartis AG's Itvisma Gene Therapy Approved by FDA for Spinal Muscular Atrophy Treatment12 days ago
benzinga.comFDA OKs Novartis SMA Treatment As First Gene Therapy Option For Kids, Teens And Adults13 days ago
prnewswire.comNovartis receives FDA approval for Itvisma, the only gene replacement therapy for children two years and older, teens, and adults with spinal muscular atrophy (SMA)13 days ago
benzinga.comTrump Unveils $200 Billion Trade Deal With Switzerland And Liechtenstein To Cull $38.5 Billion US Goods Deficit By 202823 days ago
benzinga.comNovartis' Investigational Medicine Shows Potent Activity Against Drug-Resistant Malaria Strains24 days ago